ArticleScientific reports2025
Genetic and computational analysis of AKR1C4 gene rs17134592 polymorphism in breast cancer among the Bangladeshi population.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A comprehensive in silico investigation into the deleterious nonsynonymous single nucleotide polymorphisms of the human transcription factor EB (TFEB) gene and their predicted association with cancer.Journal, genetic engineering & biotechnology · 2026Article
- Lipid metabolism-related gene expression predicts prognostic outcomes in lung adenocarcinoma.Translational cancer research · 2026Article
- Comprehensive analysis of the deleterious nonsynonymous, non-coding SNPs and cancer variants of human aldo-keto reductase type 1 (AKR1C1) protein and their probable association with disease risk and progression: a computational study.Biochemistry and biophysics reports · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is characterized by the unchecked proliferation of breast cells. Variations in the metabolism of steroid hormones can influence the risk of this disease by modifying the concentration and the potency of these hormones. The enzyme AKR1C4, primarily found in the liver, is crucial for regulating these hormone levels in the bloodstream. This research examined the relationship between a polymorphic variant (rs17134592) of the AKR1C4 gene and the susceptibility to breast cancer among the Bangladeshi population. A case-control study was conducted with 310 breast cancer patients and 310 healthy individuals from Bangladesh. DNA was extracted using an organic process, followed by genotyping through the PCR-RFLP technique. To validate the accuracy of genotyping results, a subset of PCR products was randomly selected and confirmed using Sanger sequencing. Statistical assessments were conducted to analyze the association of polymorphism, while molecular dynamics simulation and diverse computational methods were employed to predict the structural and functional impacts of the SNP. The results indicate that rs17134592 in the AKR1C4 gene is linked with a heightened risk for breast cancer (p < 0.0001, OR = 3.39, 95% CI = 1.80 to 6.50 for the GG genotype in additive model 2). The recessive model (GG vs. CC + CG) also showed an enhanced risk of susceptibility to breast malignancy (p < 0.0001, OR = 3.25, 95% CI = 1.78 to 6.08). In the subgroup of post-menopausal women, the risk of developing breast cancer was significantly higher for carriers of the GG genotype, with relative risks of 4.02 and 3.92, in the additive model 2 and recessive model, respectively. However, no significant correlations were observed between these genotypes and tumor grade or size in breast cancer patients. Computational analysis suggested that the L311V mutation (rs17134592) could potentially reduce the stability of the protein. Additionally, molecular dynamics simulations indicated that the L311V mutation introduces notable conformational instability to the AKR1C4 enzyme, potentially impacting its biological functionality and catalytic efficiency. In conclusion, the genetic variant rs17134592 has been identified as significantly correlated with the prevalence of breast cancer in the Bangladeshi population. Computational studies suggest that the L311V mutation in the AKR1C4 gene, corresponding to rs17134592, results in marked conformational instability and changes in enzyme functionality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.